These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26296528)

  • 21. Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer.
    Purnell JQ; Bland LB; Garzotto M; Lemmon D; Wersinger EM; Ryan CW; Brunzell JD; Beer TM
    J Lipid Res; 2006 Feb; 47(2):349-55. PubMed ID: 16299398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
    Riddler SA; Li X; Chu H; Kingsley LA; Dobs A; Evans R; Palella F; Visscher B; Chmiel JS; Sharrett A
    HIV Med; 2007 Jul; 8(5):280-7. PubMed ID: 17561873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Changes in Androgen-Deprived Nondiabetic Men With Prostate Cancer Are Not Mediated by Cytokines or aP2.
    Gagliano-Jucá T; Burak MF; Pencina KM; Li Z; Edwards RR; Travison TG; Basaria S
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3900-3908. PubMed ID: 30032274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol.
    Siltari A; Riikonen J; Koskimäki J; Pakarainen T; Ettala O; Boström P; Seikkula H; Kotsar A; Tammela T; Helminen M; Raittinen PV; Lehtimäki T; Fode M; Østergren P; Borre M; Rannikko A; Marttila T; Salonen A; Ronkainen H; Löffeler S; Murtola TJ
    BMJ Open; 2022 Apr; 12(4):e050264. PubMed ID: 35487730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer.
    Greenspan SL; Coates P; Sereika SM; Nelson JB; Trump DL; Resnick NM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6410-7. PubMed ID: 16189261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and androgen deprivation therapy in metabolic complications of prostate cancer patients.
    Yuan JQ; Xu T; Zhang XW; Yu LP; Li Q; Liu SJ; Huang XB; Wang XF
    Chin Med J (Engl); 2012 Oct; 125(20):3725-9. PubMed ID: 23075732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?
    Castle KO; Hoffman KE; Levy LB; Lee AK; Choi S; Nguyen QN; Frank SJ; Pugh TJ; McGuire SE; Kuban DA
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):693-9. PubMed ID: 22836052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worsening of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in patients with prostate cancer after androgen deprivation therapy.
    Oka R; Utsumi T; Endo T; Yano M; Kamijima S; Kamiya N; Suzuki H
    Asian J Androl; 2018; 20(6):634-636. PubMed ID: 29862991
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes.
    Mayasari DS; Taufiq N; Hariawan H
    BMC Cardiovasc Disord; 2021 Jul; 21(1):362. PubMed ID: 34330221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complex metabolic and skeletal changes in men taking long-term androgen deprivation therapy.
    Ziaran S; Goncalves FM; Sn JB
    Clin Genitourin Cancer; 2013 Mar; 11(1):33-8. PubMed ID: 23000203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the severity of obstructive sleep apnea and the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol.
    Kawano Y; Tamura A; Kadota J
    Metabolism; 2012 Feb; 61(2):186-92. PubMed ID: 21820142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
    Kasuya G; Ishikawa H; Tsuji H; Nomiya T; Makishima H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Haruyama Y; Kobashi G; Tsujii H;
    Cancer; 2016 Oct; 122(20):3225-3231. PubMed ID: 27351298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of androgen deprivation therapy.
    Choi SM; Kam SC
    Korean J Urol; 2015 Jan; 56(1):12-8. PubMed ID: 25598932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer.
    Planas J; Celma A; Placer J; Cuadras M; Regis L; Gasanz C; Trilla E; Salvador C; Lorente D; Morote J
    Scand J Urol; 2016 Dec; 50(6):425-428. PubMed ID: 27628623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study.
    Iimori S; Mori Y; Akita W; Takada S; Kuyama T; Ohnishi T; Shikuma S; Ishigami J; Tajima M; Asai T; Okado T; Kuwahara M; Sasaki S; Tsukamoto Y
    Clin Exp Nephrol; 2012 Dec; 16(6):930-7. PubMed ID: 22581064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes.
    Edelman S; Liauw SL; Rossi PJ; Cooper S; Jani AB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1473-9. PubMed ID: 22245201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis.
    Novikova DS; Popkova TV; Lukina GV; Luchikhina EL; Karateev DE; Volkov AV; Novikov AA; Aleksandrova EN; Nasonov EL
    J Korean Med Sci; 2016 Feb; 31(2):202-7. PubMed ID: 26839473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.